---
title: "688117.SH (688117.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688117.SH/news.md"
symbol: "688117.SH"
name: "688117.SH"
parent: "https://longbridge.com/en/quote/688117.SH.md"
datetime: "2026-05-21T17:55:05.011Z"
locales:
  - [en](https://longbridge.com/en/quote/688117.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688117.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688117.SH/news.md)
---

# 688117.SH (688117.SH) — Related News

### [SNSW: Acetate Terlipressin raw material has completed FDA filing in the United States](https://longbridge.com/en/news/287193688.md)
*2026-05-21T09:44:04.000Z*
> SNSW announced that its wholly-owned subsidiary Chengdu SNSW Pharmaceutical Co., Ltd.'s Acetyltriptorelin raw material h

### [Directly hitting the SNSW on-site communication meeting, more than 20 investors entered the company's headquarters in Chengdu](https://longbridge.com/en/news/286636656.md)
*2026-05-16T06:47:55.000Z*
> On the occasion of the "5·15 National Investor Protection Publicity Day," in order to build a bridge for communication b

### [Directly hitting SNSW's 2025 Annual Shareholders' Meeting: Strong demand for peptide raw materials, the company steadily increases production capacity](https://longbridge.com/en/news/286636648.md)
*2026-05-16T06:47:50.000Z*
> On the afternoon of May 15th, SNSW (688117) held its 2025 annual shareholders' meeting in Chengdu. Securities Times·e Co

### [SNSW: The raw material drug Teriparatide has completed the filing with the U.S. FDA](https://longbridge.com/en/news/285916507.md)
*2026-05-11T09:45:41.000Z*
> SNSW's wholly-owned subsidiary Chengdu SNSW Pharmaceutical Co., Ltd. has completed the DMF filing with the U.S. FDA for 

### [Over 30 pharmaceutical companies released their Q1 reports: some made huge profits while others incurred losses, intensifying industry differentiation](https://longbridge.com/en/news/284207900.md)
*2026-04-27T11:34:10.000Z*
> The financial reports of the A-share pharmaceutical sector for the first quarter show an increasing divergence in the in

### [The sales guidance growth for 2026 is optimistic, the innovative drug concept is experiencing a rebound, and Junshi Biosciences is favored again](https://longbridge.com/en/news/282486262.md)
*2026-04-13T02:54:11.000Z*
> On April 13th, the innovative drug concept rebounded, with Junshi Biosciences rising over 10%. Data from the National Me

### [SNSW: Wholly-owned subsidiary Meishan Huilong has obtained a drug manufacturing license](https://longbridge.com/en/news/280991027.md)
*2026-03-30T09:35:17.000Z*
> SNSW's wholly-owned subsidiary Meishan Huilong Pharmaceutical Technology Co., Ltd. recently obtained the "Drug Manufactu

### [](https://longbridge.com/en/news/280937483.md)
*2026-03-30T01:39:57.000Z*
> A-share CRO concept stocks experienced a surge, with Dongcheng Biochem and Menovo both hitting the daily limit, PR risin